CONTEMPORARY CLINICAL CONSIDERATIONS OF INFERTILITY DUE TO ENDOMETRIOSIS
Main Article Content
Abstract
The development of organ-preserving approaches to the treatment of uterine fibroids began in parallel with the introduction of radical surgical methods. However, for many years, conservative strategies lagged behind and had relatively few advocates. In recent decades, organ-preserving interventions have moved into the forefront of gynecological practice. This shift is both logical and expected, being driven by advancements in medical technologies as well as the increasing demand among women for solutions that safeguard reproductive potential. Several factors explain this trend. On the one hand, there is a steady rise in pregnancies occurring at later reproductive ages. On the other hand, uterine fibroids are being diagnosed more frequently in young, nulliparous women. Another contributing factor is the influence of mass media and the Internet, which have begun to pay greater attention to health-related topics, including coverage of innovative medical technologies. Successful organ-preserving management of uterine fibroids requires a thorough understanding of the nature of the disease itself. The term “uterine fibroids” encompasses a heterogeneous group of pathological changes within the uterus. A clinician may describe fibroids as a single, asymptomatic 1 cm intramural nodule, or, conversely, as multiple large formations equivalent in size to a 25-week pregnancy, accompanied by profuse bleeding and compression of adjacent pelvic organs. Consequently, treatment strategies are largely determined by the accuracy of the clinical classification applied.
The existing classifications—histological and localization-based—are of limited practical value, as they do not provide sufficient guidance for clinical decision-making. In practice, current indications for hysterectomy allow conservative management only up to fibroid sizes equivalent to 12 weeks of gestation, which effectively promotes a passive approach in patients with smaller lesions. Therefore, there is a pressing need for a clinically oriented classification system that integrates such parameters as fibroid size, number of nodules, anatomical location, and the patient’s reproductive plans. Such a system would enable clinicians to determine treatment tactics more precisely and personalize therapeutic strategies in line with reproductive goals.
Article Details
Section
References
1. Ансимова П. В., Болдина Н. В. ГЕСТАЦИОННЫЙ ПИЕЛОНЕФРИТ //Студенческий форум. – 2020. – С. 9.
2. Валиев Ш. Н., Негмаджанов Б. Б. CAESAREAN SECTION IN WOMEN WITH A UTERINE SCAR. MODERN METHODS OF MANAGEMENT (LITERATURE REVIEW) //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2022. – Т. 3. – №. 3.
3. Ихтиярова Г. А., Тошева И. И. РАННЯЯ ДИАГНОСТИКА И ПРОГНОЗИРОВАНИЯ РИСКА РАЗВИТИЯ УГРОЗЫ ПРЕЖДЕВРЕМЕННЫХ РОДОВ У ЖЕНЩИН С ИНФЕКЦИЯМИ МОЧЕПОЛОВОЙ СИСТЕМЫ //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2023. – Т. 4. – №. 3.
4. Колесниченко И. В. и др. ФУНКЦИОНАЛЬНЫЕ ИЗМЕНЕНИЯ МОЧЕВЫВОДЯЩИХ ПУТЕЙ ПРИ ГЕСТАЦИОННОМ ПИЕЛОНЕФРИТЕ (ОБЗОР ЛИТЕРАТУРЫ) //ВЕСТНИК КГМА имени ИК АХУНБАЕВА. – 2023. – Т. 3. – №. 3. – С. 71-78.
5. Мусинжанова П. С. и др. ЗНАЧЕНИЕ ВОСПАЛИТЕЛЬНЫХ ПРОЦЕССОВ ГЕНИТАЛИЙ В ПРОИСХОЖДЕНИИ ЖЕНСКОГО БЕСПЛОДИЯ (ОБЗОР ЛИТЕРАТУРЫ) //International scientific review of the problems of natural sciences and medicine. – 2019. – С. 136-149.
6. Насирова З. А., Негмаджанов Б. Б. ВЛИЯНИЕ ИНТРАОПЕРАЦИОННОЙ ВНУТРИМАТОЧНОЙ КОНТРАЦЕПЦИИ НА СОСТОЯНИЕ ГУМОРАЛЬНОГО ИММУНИТЕТА //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2020. – Т. 1. – №. 2.
7. Стяжкина С. Н. и др. Состояние плацент при экстрагенитальной патологии (гестационный пиелонефрит) //StudNet. – 2021. – Т. 4. – №. 5.
8. Хасанова Д. НАРУШЕНИЕ МОЧЕИСПУСКАНИЯ У БЕРЕМЕННЫХ //Евразийский журнал медицинских и естественных наук. – 2023. – Т. 3. – №. 10. – С. 90-94.
9. Юсупова Н. А., Негмаджанов Б. Б. QIN NORMAL MIKROBIOSENOZI VA UNING REGULYASIYASI //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2020. – Т. 1. – №. 1.
10. Шкодкин С. В. Нужно ли дренировать почку при гестационном пиелонефрите? //Вестник урологии. – 2020. – Т. 8. – №. 1. – С. 49-54.
11. Шопулотова З. А., Худоярова Д. Р. ХРОНИЧЕСКИЙ ПИЕЛОНЕФРИТ И БЕРЕМЕННОСТЬ: ВЛИЯНИЕ КОМОРБИДНОСТИ И ЕГО ПРОЯВЛЕНИЯ //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2023. – Т. 4. – №. 4.
12. Azizovna N. Z., Boltaevich N. B. inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection //The American Journal of Medical Sciences and Pharmaceutical Research. – 2020. – Т. 2. – №. 09. – С. 89-95.
13. Abdukhamidovna K. D. MANAGEMENT OF PREGNANT WOMEN WITH IDIOPATIC THROMBOCYTOPENIC PURPLE //European International Journal of Multidisciplinary Research and Management Studies. – 2023. – Т. 3. – №. 02. – С. 16-21.
14. Abdukhamidovna K. D. A DIFFERENTIATED APPROACH TO THE TREATMENT OF INFERTILITY IN PCOS //American Journal Of Biomedical Science & Pharmaceutical Innovation. – 2023. – Т. 3. – №. 04. – С. 1-6.
15. Dilafruz A. The Practice-oriented approach to learning in europe //Conferencea. – 2023. – С. 79-80.
16. Shopulotova Z. A., Zubaydilloeva Z. K. THE VALUE OF ULTRASOUND DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS //Бюллетень студентов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 19-22.
17. Shopulotova Z. COMPARATIVE ANALYSIS OF CLINICAL CASES OF EXACERBATION OF CHRONIC PYELONEPHRITIS IN PREGNANT WOMEN //International Bulletin of Medical Sciences and Clinical Research. – 2023. – Т. 3. – №. 8. – С. 22-25.
18. Shopulotova Z. A., Zubaydilloeva Z. K., Khudoyarova D. R. COMORBID EVENTS IN PREGNANT WOMEN WITH PYELONEPHRITIS AND PREVENTION OF THESE CONDITIONS //Бюллетень педагогов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 35-38.
19. Shopulotova Z. A., Zubaydilloeva Z. K. THE VALUE OF ULTRASOUND DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS //Бюллетень студентов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 19-22.
20. Shopulotova Z. A. et al. PHENOMENA OF COMORBIDITY IN PREGNANT WOMEN WITH PYELONEPHRITIS.